clorazepate dipotassium has been researched along with promethazine in 4 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (promethazine) | Trials (promethazine) | Recent Studies (post-2010) (promethazine) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 3,110 | 299 | 235 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | promethazine (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 5.86 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 5.86 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 5.86 | |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.012 | |
| Procathepsin L | Homo sapiens (human) | 5.86 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.238 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.035 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0076 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0046 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.681 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 5.86 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 5.86 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.014 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.4395 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.053 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 2.431 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.596 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.02 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.744 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 4.238 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.165 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.183 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.045 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.012 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.596 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.8 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0041 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.559 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.068 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.429 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 5.86 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.287 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 5.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilaberte, I; Iruela, LM; Marcos, MA; Oliveros, S | 1 |
| Diehl, LW; Werner, V | 1 |
| Gonzales, I; Kretz, FJ; Peidersky, P | 1 |
| Schmucker, P; Schön, J; Uhlig, T | 1 |
1 review(s) available for clorazepate dipotassium and promethazine
| Article | Year |
|---|---|
[The state of psychopharmacotherapy in geriatrics 2].
Topics: Actihaemyl; Aged; Amitriptyline; Bencyclane; Cerebrovascular Circulation; Clorazepate Dipotassium; Delirium; Dementia; Depression; Dextrans; Diazepam; Glucose; Humans; Imipramine; Nitrazepam; Oxygen Consumption; Paranoid Disorders; Promethazine; Psychotropic Drugs; Sleep Wake Disorders; Trimeprazine | 1980 |
2 trial(s) available for clorazepate dipotassium and promethazine
| Article | Year |
|---|---|
[Oral premedication with clorazepate dipotassium. Comparison with oral premedication with flunitrazepam and intramuscular premedication with promethazine, pethidine and atropine in adults].
Topics: Administration, Oral; Adult; Aged; Arthroscopy; Atropine; Clorazepate Dipotassium; Female; Flunitrazepam; Humans; Injections, Intramuscular; Male; Meperidine; Middle Aged; Preanesthetic Medication; Promethazine; Prospective Studies; Single-Blind Method | 1993 |
[Optimizing anesthesiologic premedication with reference to biopsychological theories. Exemplified by the effect of dipotassium clorazepate and zolpidem in combination with promethazine].
Topics: Adult; Aged; Anxiety; Arousal; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Emotions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Personality Assessment; Preanesthetic Medication; Promethazine; Prospective Studies; Pyridines; Zolpidem | 1997 |
1 other study(ies) available for clorazepate dipotassium and promethazine
| Article | Year |
|---|---|
[Remission of benzodiazepine-resistant delirium tremens after treatment with Laborit's lytic cocktail].
Topics: Adult; Alcohol Withdrawal Delirium; Anti-Anxiety Agents; Chlorpromazine; Clorazepate Dipotassium; Drug Combinations; Drug Resistance; Humans; Injections, Intramuscular; Male; Meperidine; Promethazine; Psychoses, Alcoholic | 1989 |